ATBPF

Antibe Therapeutics Inc. ATBPF

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ATBPF LXXGF TMDIF VRCDF CNPOF EIGRQ LVCLY RXMD MGCLF MRVFF
6M -0.19 % -16.91 % -9.92 % -90.00 % -21.57 % 255.65 % -31.45 % 19.89 % -24.86 % 133.21 %
YTD -0.19 % -31.11 % -44.76 % -90.00 % 0.00 % 20.57 % -38.80 % -36.83 % -18.06 % 3.11 %
1Y -0.19 % -53.68 % -52.47 % -90.00 % -8.83 % 3.79 % -54.33 % -46.65 % -94.75 % -16.99 %
3Y -59.34 % -78.44 % -96.83 % -97.86 % -92.86 % -95.68 % -69.40 % 5 310.26 % -99.32 % 179.86 %
5Y -95.55 % -91.24 % -93.83 % -98.85 % -92.66 % -97.33 % -69.82 % 5 452.63 % -99.28 % -61.13 %
10Y -83.79 % -79.85 % -99.93 % -98.85 % -98.85 % -99.81 % -93.05 % 3 416.67 % -99.33 % -59.19 %
From the beginning -95.48 % -79.85 % -93.01 % -98.85 % -98.85 % -99.77 % -96.81 % 4 120.00 % -99.33 % -99.42 %

Dividend